Package 75907-224-04

Brand: abiraterone acetate

Generic: abiraterone acetate
NDC Package

Package Facts

Identity

Package NDC 75907-224-04
Digits Only 7590722404
Product NDC 75907-224
Description

120 TABLET in 1 BOTTLE (75907-224-04)

Marketing

Marketing Status
Marketed Since 2025-03-17
Brand abiraterone acetate
Generic abiraterone acetate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6c96e35d-9099-e164-0960-353b01420f81", "openfda": {"unii": ["EM5OCB9YJ6"], "rxcui": ["1100075"], "spl_set_id": ["0c91aa38-3b0a-232c-8eb1-55f08e8e6644"], "manufacturer_name": ["Dr. Reddys Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (75907-224-04)", "package_ndc": "75907-224-04", "marketing_start_date": "20250317"}], "brand_name": "Abiraterone Acetate", "product_id": "75907-224_6c96e35d-9099-e164-0960-353b01420f81", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 17A1 Inhibitor [EPC]", "Cytochrome P450 17A1 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "product_ndc": "75907-224", "generic_name": "Abiraterone Acetate", "labeler_name": "Dr. Reddys Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abiraterone Acetate", "active_ingredients": [{"name": "ABIRATERONE ACETATE", "strength": "250 mg/1"}], "application_number": "ANDA208416", "marketing_category": "ANDA", "marketing_start_date": "20250317", "listing_expiration_date": "20261231"}